HOME >> BIOLOGY >> NEWS
Signal for inflammation linked to Ras-induced tumor growth

Cancer progression is dependent on the ability of tumor cells to interact with and favorably influence their environment. For instance, if a tumor is going expand, it is absolutely critical that new blood vessels are formed so that an adequate blood supply is in place to feed the growing tissue. A new research study published in the November issue of Cancer Cell demonstrates that a cytokine, a chemical signal that stimulates inflammation, plays a critical role in the initiation of new vasculature formation required to promote tumor progression.

Previous research has suggested that there may be a link between cancer-associated angiogenesis and inflammation. The protooncogene Ras has also been implicated in tumor-driven blood vessel generation. Ras is abnormally activated in nearly one quarter of all human cancers and is involved in many aspects of tumor progression, including interactions between tumor cells and the surrounding environment. However, the mechanisms that underlie these interactions are unclear.

Dr. Dafna Bar-Sagi from the Department of Molecular Genetics and Microbiology at the State University of New York at Stony Brook examined whether Ras-mediated induction of the inflammatory mediator CXCL-8 was required for tumor growth and angiogenesis in a mouse model. The researchers found that CXCL-8 production was required for Ras-stimulated tumor inflammation, vascularization, and growth. In addition, inhibition of CXCL-8 function in tumors expressing Ras led to a marked decrease in tumor angiogenesis.

Molecules that modulate CXCL-8 expression are known targets of the Ras signaling pathway, establishing a physiological link between these signaling molecules. The researchers conclude that in response to Ras activation, proinflammatory cytokines such as CXCL-8 may recruit immune cells and endothelial cells to tumor sites, representing a new mechanism for cancer-driven blood vessel generation. According to Dr. Bar-Sagi, "Our findin
'"/>

Contact: Heidi Hardman
hhardman@cell.com
617-397-2879
Cell Press
15-Nov-2004


Page: 1 2

Related biology news :

1. Signaling for cartilage
2. Funnel in the eye: Signal focusing increases photosensitivity
3. Signaling proteins may represent biomarkers for melanoma
4. Signaling protein builds bigger, better bones in mice
5. Penn researchers discover how key protein stops inflammation
6. Gene variations directly link inflammation to an increased risk for lung cancer
7. p53 gene mutations and inflammation trigger skin cancer
8. Remicade data in ankylosing spondylitis show improvement in spinal mobility and spinal inflammation
9. Hot on the TRAIL of controlling inflammation in bacterial meningitis
10. NIAID supports research into etiology of fungal-induced inflammation in chronic sinusitis
11. Omega-3 fatty acids affect risk of depression, inflammation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2020)... (PRWEB) , ... February 13, 2020 , ... ... announce an exclusive interview with Nobio CEO Yoram Ashery to discuss ... Nobio is a company that combats bacteria to keep people healthy with their ...
(Date:2/7/2020)... ... February 07, 2020 , ... dicentra , a ... product, nutraceutical and dietary supplement industries, announces 2020 membership with the International Probiotics ... and research pertaining to probiotics. We are thrilled to join our IPA member ...
(Date:2/1/2020)... ... February 01, 2020 , ... Liver cancer, called hepatocellular carcinoma (HCC), occurs each ... the disease. HCC is the 5th most common cancer and the 2nd leading cause ... comes to incidence of HCC, while China has half of all patients suffering from ...
Breaking Biology News(10 mins):
(Date:1/22/2020)... ... January 20, 2020 , ... ... with WAVE Electronics, the largest independent electronics distributor in the US, to make ... Smart Home Systems with leading smart home products from a single fulfillment partner. ...
(Date:1/22/2020)... ... January 21, 2020 , ... QCDx , a private biotech company ... blood draw, today announced the sale of the proprietary RareScope™ instrument to the Carole ... used in clinical cancer research. , “The RareScope can detect and isolate intact and ...
(Date:1/10/2020)... ... January 09, 2020 , ... GenScript Biotech ... GenScript Biotech Global Forum on Jan. 14 in San Francisco, coinciding with the ... Therapy and the Booming China Market," will feature gene and cell therapy leaders ...
(Date:1/7/2020)... ... January 07, 2020 , ... ... services, today announced the launch of its VivopureX™ recombinant mouse antibodies for in ... originally obtained from rats or hamsters, which Absolute Antibody has engineered into mouse-anti-mouse ...
Breaking Biology Technology:
Cached News: